Spirometer Market Size, Share & Trends Analysis Report By Type (Hand Held, Table Top, Desktop), By Technology, By Application (Asthma, COPD, Cystic Fibrosis), By End Use, By Region, And Segment Forecasts, 2018 - 2025
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
The global sleep apnea devices market is projected to reach $10.23 billion by 2026, growing at a CAGR of 7.9% from 2018 to 2026. Sleep apnea occurs when breathing is interrupted during sleep due to airway blockages. Diagnostic devices such as polysomnography and pulse oximeters are used to diagnose sleep apnea types and determine appropriate therapeutic devices for treatment. Positive air pressure devices, oxygen devices, and oral appliances are common therapeutic devices. North America currently dominates the market due to high rates of sleep disorders, though Asia Pacific is expected to experience the fastest growth. Major players are focusing on new product development and partnerships to meet growing demand.
Remote patient monitoring devices market is estimated to increase to us$ 1,50...Rakesh Zanje
MRRSE has announced the addition of the “Global Market Study on Remote Patient Monitoring Devices: Cardiac Monitors Product Type Segment to Account for 50.9% Market Revenue Share by 2024” report to their offering.
Endoscopes Market Size, Share, And Trends Analysis Report By Product (Flexible, Disposable, Rigid), By Application (Gastrointestinal, Urology, Laparoscopy), By End Use, And Segment Forecasts, 2018 - 2025
1. The global pharmaceutical market reached $942 billion in 2011 and is expected to reach $1.12 trillion by 2022 due to population growth and an aging population.
2. The Indian pharmaceutical market is estimated to reach $55 billion by 2020, growing faster than the global market, and will be dominated by drugs for non-communicable diseases.
3. The growth of the pharmaceutical industry in both global and Indian markets is driven by increasing healthcare spending, rising incomes, and a shift toward specialty and chronic disease drugs.
To successfully develop and launch an asset it’s crucial to identify and define its commercial value early in the process. In the third webinar of the series, we briefly present the background and context of early asset development and focus in on how to successfully assess the right markets for maximizing value. Providing questions that need to be answered and an example case study in which we decide the target market for a “newly developed” NSAID.
This document summarizes a report on the global zoonotic disease treatment market. Zoonotic diseases are those spread between animals and humans. The market is driven by factors like population growth, urbanization, and increased consumption of animal proteins. However, lack of disease awareness, high research costs, and drug prices restrain the market. The market is expected to grow due to rising meat consumption and income levels in developing nations. North America currently dominates the market but Asia Pacific is expected to experience increased zoonotic disease prevalence due to poor sanitation. The report provides an overview, key drivers and restraints, regional analysis, and profiles major market players.
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
The global sleep apnea devices market is projected to reach $10.23 billion by 2026, growing at a CAGR of 7.9% from 2018 to 2026. Sleep apnea occurs when breathing is interrupted during sleep due to airway blockages. Diagnostic devices such as polysomnography and pulse oximeters are used to diagnose sleep apnea types and determine appropriate therapeutic devices for treatment. Positive air pressure devices, oxygen devices, and oral appliances are common therapeutic devices. North America currently dominates the market due to high rates of sleep disorders, though Asia Pacific is expected to experience the fastest growth. Major players are focusing on new product development and partnerships to meet growing demand.
Remote patient monitoring devices market is estimated to increase to us$ 1,50...Rakesh Zanje
MRRSE has announced the addition of the “Global Market Study on Remote Patient Monitoring Devices: Cardiac Monitors Product Type Segment to Account for 50.9% Market Revenue Share by 2024” report to their offering.
Endoscopes Market Size, Share, And Trends Analysis Report By Product (Flexible, Disposable, Rigid), By Application (Gastrointestinal, Urology, Laparoscopy), By End Use, And Segment Forecasts, 2018 - 2025
1. The global pharmaceutical market reached $942 billion in 2011 and is expected to reach $1.12 trillion by 2022 due to population growth and an aging population.
2. The Indian pharmaceutical market is estimated to reach $55 billion by 2020, growing faster than the global market, and will be dominated by drugs for non-communicable diseases.
3. The growth of the pharmaceutical industry in both global and Indian markets is driven by increasing healthcare spending, rising incomes, and a shift toward specialty and chronic disease drugs.
To successfully develop and launch an asset it’s crucial to identify and define its commercial value early in the process. In the third webinar of the series, we briefly present the background and context of early asset development and focus in on how to successfully assess the right markets for maximizing value. Providing questions that need to be answered and an example case study in which we decide the target market for a “newly developed” NSAID.
This document summarizes a report on the global zoonotic disease treatment market. Zoonotic diseases are those spread between animals and humans. The market is driven by factors like population growth, urbanization, and increased consumption of animal proteins. However, lack of disease awareness, high research costs, and drug prices restrain the market. The market is expected to grow due to rising meat consumption and income levels in developing nations. North America currently dominates the market but Asia Pacific is expected to experience increased zoonotic disease prevalence due to poor sanitation. The report provides an overview, key drivers and restraints, regional analysis, and profiles major market players.
Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. E-Prescribing system has replaced the phone, paper and fax based method of prescription. The system improves patient safety by reducing prescribing errors due to various reasons, such as illegible handwriting and ambiguous abbreviations. It also reduces healthcare costs over the paper based prescription systems. It permits the physician and other healthcare professionals to regenerate a new prescription, when any prescription error occurs during pharmacy operation.
COVID-19 and its Impact on the Biopharma Financing and Deal EnvironmentTim Opler
The document provides an overview of the impact of the COVID-19 pandemic on the biopharmaceutical sector. It discusses the direct impact on the pharmaceutical industry, including decreased healthcare utilization, clinical trial delays, supply chain issues, and decreased drug usage and revenue. It also covers the indirect effects, such as potential government budget constraints, drug price pressures, increased social division, and response from regulators to encourage testing and device approvals during the pandemic.
M&A in pharmaceutical industry between india and italyVishal Singh
This document provides an overview of the pharmaceutical markets in India and Italy. It begins with a summary of the global pharmaceutical market, noting that it grew to $1,324 billion in 2018, with North America making up 48% of the market. India's population growth and rising incomes are making it an attractive emerging market. The pharmaceutical market in India is divided between domestic and export markets. The revenues and lower costs of the Indian pharmaceutical industry make it competitive globally. The document then shifts to provide context on the Italian pharmaceutical market before comparing the two.
The value of early asset development and commercializationCello Health
Worldwide pharmaceutical R&D spend is increasing each year, and the competition for a share of that investment is becoming fiercer. Companies need to demonstrate the potential value of their asset in commercial as well as scientific and clinical terms.
The slides in this deck define and identify value from a financial, clinical and commercial perspective while also exploring how to derive value for patients.
Trends in Oncology Pharmaceuticals Business DevelopmentTim Opler
This presentation provides an overview of the evolving marketplace for oncology transactions and is a summary of discussion materials shared by Torreya at the Sachs Conference on September 26, 2019 in Basel, Switzerland.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of COPD Drugs Market. The report analyses the COPD Drugs Market By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, andOthers). The report analyses the COPD Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes pipeline analysis for few COPD drugs. Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-copd-drugs-market-analysis-by-drug-type-combination-therapy-anticholinergics-beta-agonist-inhaled-corticosteroids-others-pipeline-drugs-by-region-by-country-2019-edition-forecast-to-2023-r29194 COPD Drugs Market Analysis
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1
This document provides information about a market research report on the global patient monitoring devices market. The 334-page report, published in February 2015, analyzes the $24.3 billion global patient monitoring devices market, covering device types, end users, regions, company profiles, and market projections. It finds that patient monitoring plays a key role in healthcare, with cardiac monitoring currently dominating but neurological and respiratory monitoring growing the fastest. The full report can be purchased for prices ranging from $4,500 to $9,000 depending on license type.
Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors.
This report analyzes the worldwide markets for Biosensors in US$ Thousand by the following Product Applications: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 70 companies including many key and niche players such as Abbott Point Of Care, Inc., Assure Controls, Inc. , Bio-Rad Laboratories, Inc., Biolan Microbiosensores S.L, GE Healthcare Life Sciences, and F. Hoffmann-La Roche Ltd.
Patient Monitoring Devices Global Market Report 2018SainathMuntha1
The global patient monitoring devices market was valued around $20 billion in 2017. Get Sample report: https://www.thebusinessresearchcompany.com/sample.aspx?id=264&type=smp
Pediatric vaccines market, doses, immunization, cases and forecast worldwide ...Renub Research
Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to its offering
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.
Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.
Interventional Oncology Global Market estimated to be worth $2.1 billion by 2026Vinay Shiva Prasad
The document summarizes a report by IQ4I Research & Consultancy on the global interventional oncology market. Some key points:
- The global interventional oncology market is estimated to reach $2.1 billion by 2026, growing at a high single-digit CAGR from 2019 to 2026.
- Embolization currently occupies the highest market share but ablation is the fastest growing segment.
- The liver cancer application segment currently generates the highest revenue but brain & spine cancers are growing the fastest.
- North America currently dominates the market but Asia-Pacific is growing the fastest, driven by factors like an aging population and increased healthcare access.
This document provides a summary of the global patient monitoring market from 2012-2020. It discusses key market segments such as devices (cardiac, prenatal, etc.), end-users (medical centers, home users), and regions (North America, Europe, Asia Pacific). The global market is expected to reach $XX million by 2020, growing at 5.2% annually. North America currently dominates the market but Asia Pacific is expected to see the fastest growth. Cardiac monitoring accounts for the largest segment currently but remote monitoring is growing the fastest. The report provides market size data and forecasts for each segment.
Global Veterinary Reference Laboratory (VRL) Market Research, 2018 to 2025Signitech
The global veterinary reference laboratory (VRL) market size was valued at USD 2.350 billion in 2016 and is expected to grow with CAGR of 9.1% during the forecast period.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
This document provides an overview of the global biosimilars market from 2019 to 2029. It finds that the market was valued at $9 billion in 2019 and is expected to reach over $xx billion by 2029, growing at a CAGR of xx%. The largest segments are monoclonal antibodies and oncology applications. North America has the highest current market value but Asia Pacific is expected to have the strongest growth. Key players in the biosimilars market include Pfizer, Eli Lilly, Mylan, Novartis, Teva and Samsung Biologics.
This document provides an analysis of the Taiwanese medical device industry and investment opportunities. It discusses global trends showing the US market is the largest at 50.6% and growing. Taiwan's medical device industry generated $2.14 billion in revenue in 2006 from 500 companies. The document outlines gaps in Taiwan's supply chain and niche areas for foreign investors, as well as incentives for industry investment and examples of successful foreign investments and industry-academic collaborations in Taiwan.
India Pharmaceutical 2015 A McKinsey reportDevansh Doshi
The McKinsey report predicts that the Indian pharmaceutical market will triple in size by 2015, making India one of the top 10 pharmaceutical markets in the world. Rising incomes, expanded health insurance coverage, and growth in healthcare infrastructure will fuel a pharmaceutical market worth $20 billion by 2015, more than double its current size. Chronic diseases will also become more prevalent in India, increasing demand for pharmaceutical treatments. The report finds that rural and smaller city markets will account for almost half of the growth in the pharmaceutical industry by 2015.
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
Cerebral and pulse oximeter global Market estimated to be worth $2,476.8 mill...Vinay Shiva Prasad
Factors such as increase in incidence of respiratory and cardiovascular diseases, rising adoption in homecare settings, growing use of patient monitoring devices in hospitals and launch of convenient fingertip and wrist oximeters are driving the market.
Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. E-Prescribing system has replaced the phone, paper and fax based method of prescription. The system improves patient safety by reducing prescribing errors due to various reasons, such as illegible handwriting and ambiguous abbreviations. It also reduces healthcare costs over the paper based prescription systems. It permits the physician and other healthcare professionals to regenerate a new prescription, when any prescription error occurs during pharmacy operation.
COVID-19 and its Impact on the Biopharma Financing and Deal EnvironmentTim Opler
The document provides an overview of the impact of the COVID-19 pandemic on the biopharmaceutical sector. It discusses the direct impact on the pharmaceutical industry, including decreased healthcare utilization, clinical trial delays, supply chain issues, and decreased drug usage and revenue. It also covers the indirect effects, such as potential government budget constraints, drug price pressures, increased social division, and response from regulators to encourage testing and device approvals during the pandemic.
M&A in pharmaceutical industry between india and italyVishal Singh
This document provides an overview of the pharmaceutical markets in India and Italy. It begins with a summary of the global pharmaceutical market, noting that it grew to $1,324 billion in 2018, with North America making up 48% of the market. India's population growth and rising incomes are making it an attractive emerging market. The pharmaceutical market in India is divided between domestic and export markets. The revenues and lower costs of the Indian pharmaceutical industry make it competitive globally. The document then shifts to provide context on the Italian pharmaceutical market before comparing the two.
The value of early asset development and commercializationCello Health
Worldwide pharmaceutical R&D spend is increasing each year, and the competition for a share of that investment is becoming fiercer. Companies need to demonstrate the potential value of their asset in commercial as well as scientific and clinical terms.
The slides in this deck define and identify value from a financial, clinical and commercial perspective while also exploring how to derive value for patients.
Trends in Oncology Pharmaceuticals Business DevelopmentTim Opler
This presentation provides an overview of the evolving marketplace for oncology transactions and is a summary of discussion materials shared by Torreya at the Sachs Conference on September 26, 2019 in Basel, Switzerland.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of COPD Drugs Market. The report analyses the COPD Drugs Market By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, andOthers). The report analyses the COPD Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes pipeline analysis for few COPD drugs. Request free Sample of this Report @ http://azothanalytics.com/report/healthcare-pharma/global-copd-drugs-market-analysis-by-drug-type-combination-therapy-anticholinergics-beta-agonist-inhaled-corticosteroids-others-pipeline-drugs-by-region-by-country-2019-edition-forecast-to-2023-r29194 COPD Drugs Market Analysis
Visit us: http://azothanalytics.com/research/healthcare-pharma-c1
This document provides information about a market research report on the global patient monitoring devices market. The 334-page report, published in February 2015, analyzes the $24.3 billion global patient monitoring devices market, covering device types, end users, regions, company profiles, and market projections. It finds that patient monitoring plays a key role in healthcare, with cardiac monitoring currently dominating but neurological and respiratory monitoring growing the fastest. The full report can be purchased for prices ranging from $4,500 to $9,000 depending on license type.
Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors.
This report analyzes the worldwide markets for Biosensors in US$ Thousand by the following Product Applications: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 70 companies including many key and niche players such as Abbott Point Of Care, Inc., Assure Controls, Inc. , Bio-Rad Laboratories, Inc., Biolan Microbiosensores S.L, GE Healthcare Life Sciences, and F. Hoffmann-La Roche Ltd.
Patient Monitoring Devices Global Market Report 2018SainathMuntha1
The global patient monitoring devices market was valued around $20 billion in 2017. Get Sample report: https://www.thebusinessresearchcompany.com/sample.aspx?id=264&type=smp
Pediatric vaccines market, doses, immunization, cases and forecast worldwide ...Renub Research
Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to its offering
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.
Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.
Interventional Oncology Global Market estimated to be worth $2.1 billion by 2026Vinay Shiva Prasad
The document summarizes a report by IQ4I Research & Consultancy on the global interventional oncology market. Some key points:
- The global interventional oncology market is estimated to reach $2.1 billion by 2026, growing at a high single-digit CAGR from 2019 to 2026.
- Embolization currently occupies the highest market share but ablation is the fastest growing segment.
- The liver cancer application segment currently generates the highest revenue but brain & spine cancers are growing the fastest.
- North America currently dominates the market but Asia-Pacific is growing the fastest, driven by factors like an aging population and increased healthcare access.
This document provides a summary of the global patient monitoring market from 2012-2020. It discusses key market segments such as devices (cardiac, prenatal, etc.), end-users (medical centers, home users), and regions (North America, Europe, Asia Pacific). The global market is expected to reach $XX million by 2020, growing at 5.2% annually. North America currently dominates the market but Asia Pacific is expected to see the fastest growth. Cardiac monitoring accounts for the largest segment currently but remote monitoring is growing the fastest. The report provides market size data and forecasts for each segment.
Global Veterinary Reference Laboratory (VRL) Market Research, 2018 to 2025Signitech
The global veterinary reference laboratory (VRL) market size was valued at USD 2.350 billion in 2016 and is expected to grow with CAGR of 9.1% during the forecast period.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
This document provides an overview of the global biosimilars market from 2019 to 2029. It finds that the market was valued at $9 billion in 2019 and is expected to reach over $xx billion by 2029, growing at a CAGR of xx%. The largest segments are monoclonal antibodies and oncology applications. North America has the highest current market value but Asia Pacific is expected to have the strongest growth. Key players in the biosimilars market include Pfizer, Eli Lilly, Mylan, Novartis, Teva and Samsung Biologics.
This document provides an analysis of the Taiwanese medical device industry and investment opportunities. It discusses global trends showing the US market is the largest at 50.6% and growing. Taiwan's medical device industry generated $2.14 billion in revenue in 2006 from 500 companies. The document outlines gaps in Taiwan's supply chain and niche areas for foreign investors, as well as incentives for industry investment and examples of successful foreign investments and industry-academic collaborations in Taiwan.
India Pharmaceutical 2015 A McKinsey reportDevansh Doshi
The McKinsey report predicts that the Indian pharmaceutical market will triple in size by 2015, making India one of the top 10 pharmaceutical markets in the world. Rising incomes, expanded health insurance coverage, and growth in healthcare infrastructure will fuel a pharmaceutical market worth $20 billion by 2015, more than double its current size. Chronic diseases will also become more prevalent in India, increasing demand for pharmaceutical treatments. The report finds that rural and smaller city markets will account for almost half of the growth in the pharmaceutical industry by 2015.
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
Cerebral and pulse oximeter global Market estimated to be worth $2,476.8 mill...Vinay Shiva Prasad
Factors such as increase in incidence of respiratory and cardiovascular diseases, rising adoption in homecare settings, growing use of patient monitoring devices in hospitals and launch of convenient fingertip and wrist oximeters are driving the market.
COPD and Asthma Devices Market PPT: Growth, Outlook, Demand, Keyplayer Analys...IMARC Group
The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
More Info:- https://www.imarcgroup.com/copd-asthma-devices-market
Respiratory devices are used to mechanically supply respiratory gas or oxygen to the patients with impaired respiratory function. The currently available innovative respiratory devices automatically adjust inhalations and exhalations according to the patient’s requirement. The devices are also available in various versions such as emergency respiratory devices for rescue application, long-term respiratory devices for intensive care, and mobile home respiratory devices.
Global Influenza Diagnostics Market Size Was Valued at USD 1.11 Billion in 2022, and is Projected to Reach USD 1.47 Billion by 2030, Growing at a CAGR of 3.6% From 2023-2030.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
The surgical microscope market is expected to exceed $1,740.4 million by 2026, growing at a CAGR of 12.5%. In 2017, ophthalmic microscopes dominated the market. North America accounted for the largest share due to increasing healthcare spending and surgical procedures. Key growth drivers include rising disease prevalence, technological advancements, and growing geriatric populations. Major players are expanding through acquisitions and new product development to capitalize on the market opportunity in both developed and emerging countries.
Multiple factors are leading to increase in demand for ventilators. Some of the include increased focus on intensive care and rapidly rising population of geriatric population worldwide. To compound the situation further is increase in chronic diseases. As the world sees failing health owing to lifestyle changes and demographics shift, market for ventilators chart an upward growth.
Aerosol Delivery Devices Market PPT: Overview, Dynamics, Trends, Segmentation...IMARC Group
The global aerosol delivery devices market size reached US$ 47.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 73.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.
More Info:- https://www.imarcgroup.com/aerosol-delivery-devices-market
Australia Lung Cancer Drugs Market Analysis Sample ReportInsights10
Lung cancer is the fifth most common type of cancer affecting the Australian population, therefore the Australian lung cancer drugs market is projected to grow during the forecast period. The market is segmented by type, treatment, end user, route of administration, and distribution channel. To get a detailed report, contact us at - info@insights10.com
Acute Respiratory Distress Syndrome MarketRenub Research
According to Renub Research’s latest report “Acute Respiratory Distress Syndrome Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” Acute Respiratory Distress Syndrome Market is estimated to reach US$ 1.83 Billion by 2028.
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
Aerosol Delivery Devices Market by Product Type, Distribution Channel, End Us...IMARC Group
The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
More Info:- https://www.imarcgroup.com/aerosol-delivery-devices-market
The global neonatal ventilator market size reached US$ 423.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 699.7 Million by 2032, exhibiting a growth rate (CAGR) of 5.58% during 2024-2032.
More Info:- https://www.imarcgroup.com/neonatal-ventilator-market
The global life science instrumentation market is projected to reach $91 billion by 2024, driven by technological advancements, increased investment in life science research, and growing concerns about food safety. Key factors such as rising prevalence of infectious diseases and high R&D spending by major players are also fueling market growth. The market is segmented by type, application, and region. Major players are involved in partnerships and new product development to gain a competitive advantage in this expanding market.
Laparoscopy is a minimally invasive surgical technique performed through a keyhole incision. A small camera along with a light source attached to a tube enables surgeons to maneuver special laparoscopic devices to the target area and carry out the surgery. This technique is mainly preferred for carrying out surgeries related to the pancreas, liver, colon and bile duct.
Portable Oxygen Concentrators Market PPT: Demand, Trends and Business Opportu...IMARC Group
The global portable oxygen concentrators market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
More Info:- https://www.imarcgroup.com/portable-oxygen-concentrators-market
Patient Monitoring Devices Global Market estimated to be worth $42,974.9 mill...Vinay Shiva Prasad
The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth.
The global audiology devices market is expected to reach $9.5 billion by 2020, growing at an estimated 5% CAGR from 2014 to 2020. Technological advancements in wireless devices and increased demand from geriatric populations are fueling market growth. Hearing aids dominated the market in 2013 with 64.1% share due to enhanced comfort, connectivity and usability. Asia Pacific is expected to experience the fastest growth due to improving healthcare infrastructure and growing populations in countries like India and China.
Dermatology Devices Market Size, Share & Trends Analysis Report By End Use (Clinics, Hospitals), By Product & Application (Diagnostic, Treatment), By Region, And Segment Forecasts, 2018 - 2025
Hair Removal Devices Market Size, Share & Trends Analysis Report By Product (Laser, Intense Pulse Light), By End Use (Beauty, Dermatology Clinics, Home Use), By Region, And Segment Forecasts, 2018 - 2025
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 - 2025
Patient Handling Equipment Market Analysis By Product (Wheelchairs & Scooters, Medical Beds, Mechanical & Nonmechanical Equipment, Ambulatory Aids), By Type (Bariatric Care, Fall Prevention, Critical Care, Wound Care), By End Use (Home Care Settings, Hospitals, Elderly Care Facilities), And Segment Forecasts To 2024
The global medical carts market was valued at USD 1.28 billion in 2016 and is expected to witness a CAGR of 15.2% during the forecast period. Increasing adoption of electronic medical records and demand for efficient patient care are driving market growth. By product, mobile computing carts accounted for the largest share in 2016 due to increased applications in healthcare facilities. Geographically, North America dominated the market in 2016 owing to rising musculoskeletal injuries among hospital staff in the region.
The global cell line development market was estimated at $2.67 billion in 2015 and is anticipated to grow at a CAGR of 12.9% from 2022 to reach $6.24 billion. Increasing demand for monoclonal antibodies and patent expirations of blockbuster biologics are expected to drive market growth. North America was the largest market in 2014 due to factors such as adoption of cell culture techniques, supportive government initiatives, and high healthcare spending. Asia Pacific is anticipated to register rapid growth over the forecast period due to presence of CROs, growing R&D investments, and increasing biologics production.
The global biopharmaceutical excipients market was valued at $1.67 billion in 2017 and is expected to grow at a CAGR of 6.08% through 2025. Key drivers of growth include the expansion of the biopharmaceutical industry and increasing production capacities. Carbohydrates currently have the largest market share due to wide use of excipients like dextrose, sucrose, and starch. Polyols are projected to be the fastest growing segment due to their ability to reduce protein degradation. North America currently leads the market due to major biopharmaceutical manufacturers located in the US.
Prosthetics and Orthotics Market, Prosthetics and Orthotics Industry, Prosthetics and Orthotics Market 2018, Prosthetics and Orthotics Market Size, Prosthetics and Orthotics Market Share, Prosthetics and Orthotics Market Revenue, Prosthetics and Orthotics Market 2025
In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
The global neurostimulation devices market size was valued at USD 4.07 billion in 2016 and is anticipated to witness a CAGR of 11.7% during the forecast period. Spinal cord stimulation devices currently dominate the market with over 54% share. Pain management is the largest application segment, accounting for over 65% of total revenue in 2015. North America currently dominates the market due to high patient awareness levels and sophisticated healthcare infrastructure in countries like the US and Canada.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
Spirometer market
1. FollowUs:
Spirometer Market Size, Industry Share, Estimate And Future Growth To
2025 | Grand View Research, Inc
The global spirometer market size is expectedto reach around USD 1.3 billionby 2025, according to a newreport by
Grand ViewResearch, Inc., expandingat a CAGR of 9.4% over the forecast period.Chronic respiratory diseasesare
rising among adults and children worldwide.Over2 billionpeople are currently estimatedto be exposedto air
pollutionon a regular basis,driving the incidence rate of respiratory disorders. Diagnosisand monitoring of
respiratory diseaseshas become crucial in hospitalsas well as home settings.
Around 230 millionpeople are affectedby asthma across the globe.In addition, around 30% of pediatric
hospitalizationsare attributed to asthma. Asthma and related respiratory disorders have beenincreasing due to
worseningenvironmental conditions. Spirometry is an effective method to diagnose and monitor respiratory health.
The American Thoracic Society and the European Respiratory Society have been proactivelyworking on the
standardization of spirometrymeasurements and global guidelines.
The developedcountriessuch as U.S. have reimbursementpoliciesdedicatedfor spirometry through Medicare,
Medicaid, and third-party insurance. The national spirometryamounts were increased due to revisedMedicare Fee
Schedule,2018.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/spirometer-market
“The global spirometer market size was valued at USD 672.5 million in 2017
and is expected to expand at a CAGR of 9.4% over the forecast period.”
2. FollowUs:
Further key findings from the report suggest:
Steadfast increase in prevalence of Chronic Obtrusive Pulmonary Diseases (COPD) and adoption of
technologicallyadvanced diagnostic devicesare some of the key drivers accountable for the growth of
spirometersmarket across the globe
In 2017, table top spirometersdominated the type segment in terms of revenue as they are widelyusedin
hospitals,clinics, and other diagnostic centers
Desktop spirometersare likelyto witnessthe fastest growth in the coming years as the computer-based
spirometry has become more popular among physicians as it reduces paperwork and offersautomatic result
interpretation
Flow measurementspirometersdominated the technology segmentin terms of revenue share in the year
2017. Peak flowmeasurement spirometersare anticipated to grow at the fastest rate over the forecast period
Among applications, COPD held majority of the market share in 2017 pertaining to steep rise in cases of COPD
across the globe. Whereas, asthma is expectedto grow at the fastest rate in the years to come
In the end use segment,hospitals and clinics heldthe largest market share in 2017 due to extensive use of
spirometry in primary care settings. However, home healthcare is likelyto experience impressive growthrate
in the coming years
North America dominatedthe market in terms of revenue share in 2017 as it has a large patient base with
respiratory disorders.On the other hand, Asia Pacific is projected to showcase the fastest growth rate due to
emergingeconomies such as China and India
The market is witnessingdevelopmentsof technologicallyadvanced devices.In February 2015, Cohero Health,
a U.S.-based company, receivedapproval by the FDA for its hand heldspirometer.This mobile spirometeris
based on wirelesstechnology and can be paired with computers, smart phones, and tablets for real-time
monitoring and reporting
Some of the key players in the spirometermarket are Smiths Medical, Schiller AG, Nihon KohdenCorporation,
and others.
Grand ViewResearch has segmentedthe global spirometer market based on type, technology, application,end use,
and region:
Spirometer Type Outlook (Revenue, USD Million, 2014 - 2025)
Hand Held
Table Top
Desktop
Spirometer Technology Outlook (Revenue,USD Million, 2014 - 2025)
Volume Measurement
Flow Measurement
Peak Flow Measurement
Spirometer Application Outlook (Revenue,USD Million, 2014 - 2025)
3. FollowUs:
Asthma
COPD
Cystic Fibrosis
Pulmonary Fibrosis
Others
Spirometer End Use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals & Clinics
Home Healthcare
Spirometer Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
o U.S.
o Canada
Europe
o U.K.
o Germany
o France
o Italy
o Spain
Asia Pacific
o Japan
o China
o India
Latin America
o Brazil
o Mexico
Middle East & Africa
o South Africa
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/medical-devices
Table of Content of Spirometer Market
9. FollowUs:
About Us:
Grand ViewResearch, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To helpclients make informed business decisions, the company offers
market intelligence studiesensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist,USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com